ReviewExpert opinion on drug discovery2022

The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19.

Christiana Mantzourani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.